4
Changes in Ownership
CytomX Therapeutics, Inc. Filed Acc 0001140361-17-011297
Chief Financial Officer acquired 2,500 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Goeltz II Robert C. · Chief Financial Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2017-03-09 | Exercise or conversion : show line 1 in the form | +2,500 | $4.47 | $11,182 | 9,789 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2017-03-09 | Exercise or conversion : show line 2 in the form Stock Option (right to buy) | −2,500 | 239,175 | D |
Loading xslF345X03/doc1.xml…